Low-dose vitamin K2 (MK-4) supplementation for 12 months improves bone metabolism and prevents forearm bone loss in postmenopausal Japanese women

Journal of Bone and Mineral Metabolism

Volumn 32, Issue 2, 2014, Pages 142-150

  Koitaya, Noriko ^a   Sekiguchi, Mariko ^a   Tousen, Yuko ^a   Nishide, Yoriko ^a   Morita, Akemi ^a   Yamauchi, Jun ^a   Gando, Yuko ^a   Miyachi, Motohiko ^a   Aoki, Mami ^b   Komatsu, Miho ^b   Watanabe, Fumiko ^b   Morishita, Koji ^b   Ishimi, Yoshiko ^a  

^a NATIONAL INSTITUTE OF HEALTH AND NUTRITION   (Japan)

^b KYOWA HAKKO BIO CO   (Japan)

Author keywords

Bone mineral density; MK 4; Osteocalcin; Pentosidine; Postmenopausal women

Indexed keywords

25 HYDROXYVITAMIN D; ADIPONECTIN; ALKALINE PHOSPHATASE; CREATININE; ESTRADIOL; FARNOQUINONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MAGNESIUM; OSTEOCALCIN; PENTOSIDINE; PHOSPHORUS; PHYTOMENADIONE; TRIACYLGLYCEROL; VITAMIN K GROUP; BIOLOGICAL MARKER;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; BODY MASS; BONE DENSITY; BONE METABOLISM; BONE TURNOVER; CALCIUM INTAKE; CALORIC INTAKE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ESTRADIOL BLOOD LEVEL; FAT INTAKE; FEMALE; FOREARM; HUMAN; IRON INTAKE; JAPANESE; LOW DRUG DOSE; OSTEOLYSIS; OSTEOPOROSIS; PHYSICAL ACTIVITY; POSTMENOPAUSE; POTASSIUM INTAKE; PRIORITY JOURNAL; PROTEIN INTAKE; RANDOMIZED CONTROLLED TRIAL; SALT INTAKE; TRIACYLGLYCEROL BLOOD LEVEL; URINALYSIS; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; BLOOD; DIET SUPPLEMENTATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; JAPAN; METABOLISM; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; QUESTIONNAIRE; TIME; URINE;

AGED; BIOLOGICAL MARKERS; BONE DENSITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIETARY SUPPLEMENTS; FEMALE; FOREARM; HUMANS; JAPAN; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; POSTMENOPAUSE; QUESTIONNAIRES; TIME FACTORS; VITAMIN K 2;

EID: 84898801296     PISSN: 09148779     EISSN: 14355604     Source Type: Journal    
DOI: 10.1007/s00774-013-0472-7     Document Type: Article

References (36)

1. Vermeer C (1990) Gamma-carboxyglutamate-containing proteins and the vitamin-K-dependent carboxylase. Biochem J 266:625-636
2. Adams J, Pepping J (2005) Vitamin K in the treatment and prevention of osteoporosis and arterial calcification. Am J Health Syst Pharm 62:1574-1581 (Pubitemid 41060468)
3. 2) in mice: two possible routes for menaquinone-4 accumulation in cerebra of mice. J Biol Chem 283:11270-11279
4. 2 in bone metabolism and osteoporosis. Altern Med Rev 10:24-35
5. 2 (menatetrenone) on bone metabolism in postmenopausal women. Endocr J 49:363-370
6. 3 and estrogen-progestin therapy. Maturitas 31:161-164
7. Ishida Y, Kawai S (2004) Comparative efficacy of hormone replacement therapy, etidronate, calcitonin, alfacalcidol, and vitamin K in postmenopausal women with osteoporosis: the Yamaguchi Osteoporosis Prevention Study. Am J Med 117:549-555 (Pubitemid 39304204)
8. 2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis. J Bone Miner Res 15:515-521
9. Cockayne S, Adamson J, Lanham-New S, Shearer MJ, Gilbody S, Torgerson DJ (2006) Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials. Arch Intern Med 166:1256-1261 (Pubitemid 43967576)
10. Binkley NC, Krueger DC, Kawahara TN, Engelke JA, Chappell RJ, Suttie JW (2002) A high phylloquinone intake is required to achieve maximal osteocalcin gamma-carboxylation. Am J Clin Nutr 76:1055-1060 (Pubitemid 35244677)
11. Fang Y, Hu C, Tao X, Wan Y, Tao F (2012) Effect of vitamin K on bone mineral density: a meta-analysis of randomized controlled trials. J Bone Miner Metab 30:60-68
12. 2 (MK-4) supplementation on bio-indices in postmenopausal Japanese women. J Nutr Sci Vitaminol 55:15-21
13. Ministry of Health, Labour, and Welfare, Japan (2010) Dietary reference intakes for Japanese. Daiichi Shuppan, Tokyo
14. Booth SL, Martini L, Peterson JW, Saltzman E, Dallal GE, Wood RJ (2003) Dietary phylloquinone depletion and repletion in older women. J Nutr 133:2565-2569 (Pubitemid 36935971)
15. Kaneki M, Hodges SJ, Hosoi T, Fujiwara S, Lyons A, Crean SJ, Ishida N, Nakagawa M, Takechi M, Sano Y, Mizuno Y, Hoshino S, Miyao M, Inoue S, Horiki K, Shiraki M, Ouchi Y, Orimo H (2001) Japanese fermented soybean food as the major determinant of the large geographic difference in circulating levels of vitamin K2: possible implications for hip-fracture risk. Nutrition 17:315-321 (Pubitemid 32454984)
16. Tsugawa N, Shiraki M, Suhara Y, Kamano M, Ozaki R, Tanaka K, Okano T (2008) Low plasma phylloquinone concentration is associated with high incidence of vertebral fracture in Japanese women. J Bone Miner Metab 26:79-85 (Pubitemid 350308003)
17. 1 epoxide in human plasma with electrofluorimetric reaction detection. J Chromatogr 289:377-385
18. Kagawa Y (2005) Standard tables of food composition in Japan. 5th revised edition. Kagawa Education Institute of Nutrition, Tokyo
19. Tsugawa N, Shiraki M, Suhara Y, Kamano M, Tanaka K, Okano T (2006) Vitamin K status of healthy Japanese women: age-related vitamin K requirement for γ-carboxylation of osteocalcin. Am J Clin Nutr 83:380-386 (Pubitemid 44713201)
20. Knapen MH, Nieuwenhuijzen Kruseman AC, Wouters RS, Vermeer C (1998) Correlation of serum osteocalcin fractions with bone mineral density in women during the first 10 years after menopause. Calcif Tissue Int 63:375-379 (Pubitemid 28476325)
21. Sokoll LJ, Sadowski JA (1996) Comparison of biochemical indexes for assessing vitamin K nutritional status in a healthy adult population. Am J Clin Nutr 63:566-573 (Pubitemid 26099250)
22. Szulc P, Chapuy MC, Meunier PJ, Delmas PD (1993) Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J Clin Invest 91:17-74
23. Knapen MH, Jie KS, Hamulyak K, Vermeer C (1993) Vitamin K-induced changes in markers for osteoblast activity and urinary calcium loss. Calcif Tissue Int 53:81-85 (Pubitemid 23215380)
24. Szulc P, Arlot M, Chapuy MC, Duboeuf F, Meunier PJ, Delmas PD (1994) Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly women. J Bone Miner Res 9:1591-1595 (Pubitemid 24300109)
25. Takahashi M, Naitou K, Ohishi T, Kushida K, Miura M (2001) Effect of vitamin K and/or D on undercarboxylated and intact osteocalcin in osteoporotic patients with vertebral or hip fractures. Clin Endocrinol 54:219-224 (Pubitemid 32193524)
26. 2 supplementation improves hip bone geometry and bone strength indices in postmenopausal women. Osteoporos Int 18:963-972
27. 2. Jpn J Med Pharm Sci 57:537-546
28. Bügel S (2008) Vitamin K and bone health in adult humans. Vitam Horm 78:393-416
29. Wang X, Shen X, Li X, Agrawal CM (2002) Age-related changes in the collagen network and toughness of bone. Bone (NY) 31:1-7 (Pubitemid 34754417)
30. Saito M, Marumo K (2010) Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus. Osteoporos Int 21:195-214
31. 2-activated transcription of extracellular matrix-related genes and collagen accumulation in osteoblastic cells. J Biol Chem 281:16927-16934
32. Vervoort LM, Ronden JE, Thijssen HH (1997) The potent antioxidant activity of the vitamin K cycle in microsomal lipid peroxidation. Biochem Pharmacol 54:871-876 (Pubitemid 27404594)
33. Roux C, Arabi A, Porcher R, Garnero P (2003) Serum leptin as a determinant of bone resorption in healthy postmenopausal women. Bone (NY) 33:847-852 (Pubitemid 37393496)
34. Zhang H, Xie H, Zhao Q, Xie GQ, Wu XP, Liao EY, Luo XH (2010) Relationships between serum adiponectin, apelin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in post-menopausal Chinese women. J Endocrinol Invest 33:707-711
35. Zhang Y, Zhou P, Kimondo JW (2012) Adiponectin and osteocalcin: relation to insulin sensitivity. Biochem Cell Biol 90:613-620
36. Orimo H, Nakamura T, Hosoi T, Iki M, Uenishi K, Endo N, Ohta H, Shiraki M, Sugimoto T, Suzuki T, Soen S, Nishizawa Y, Hagino H, Fukunaga M, Fujiwara S (2012) Japanese 2011 guidelines for prevention and treatment of osteoporosis: executive summary. Arch Osteoporos 7:3-20